High Efficacy of Dupilumab in Omalizumab-Refractory Severe Chronic Spontaneous Urticaria and Delayed Pressure Urticaria

被引：0

作者：

Pastor-Nieto, M. A. ^{[1
,2
,3
,4
,5
]}

Gatica-Ortega, M. E. ^{[4
]}

机构：

[1] Hosp Univ Fdn Jimenez Diaz, Serv Dermatol, Madrid, Spain

[2] Hosp Univ Guadalajara, Serv Dermatol, Guadalajara, Madrid, Spain

[3] Univ Alcala, Fac Med & Ciencias Salud, Dept Med & Especial Med, Alcala De Henares, Spain

[4] Univ Castilla La Mancha, Albacete, Spain

[5] Complejo Hospitalario Univ Toledo, Serv Dermatol, Toledo, Spain

来源：

ACTAS DERMO-SIFILIOGRAFICAS | 2025年 / 116卷 / 02期

关键词：

D O I：

10.1016/j.ad.2023.07.038

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：191 / 193

页数：3

共 50 条

[31] A severe adverse reaction to omalizumab therapy in chronic spontaneous urticaria
Dies, Laura
Sernicola, Alvise
Magri, Francesca
Chello, Camilla
Paolino, Giovanni
Carnicelli, Giorgia
Faina, Valentina
Nencini, Francesca
Grieco, Teresa
DERMATOLOGIC THERAPY, 2020, 33 (01)
[32] Unresponsiveness to Omalizumab in Chronic Spontaneous Urticaria
Riccardo Asero
Angelo V. Marzano
Massimo Cugno
Current Treatment Options in Allergy, 2020, 7 : 135 - 141
[33] Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
Sirufo, Maria Maddalena
Bassino, Enrica Maria
De Pietro, Francesca
Ginaldi, Lia
De Martinis, Massimo
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2021, 35
[34] Unresponsiveness to Omalizumab in Chronic Spontaneous Urticaria
Asero, Riccardo
Marzano, Angelo, V
Cugno, Massimo
CURRENT TREATMENT OPTIONS IN ALLERGY, 2020, 7 (02) : 135 - 141
[35] Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria
Tabanlioglu-Onan, Duru
Oktem, Ayse
Yalcin, Basak
Artuz, Ferda
ASTIM ALLERJI IMMUNOLOJI, 2019, 17 (01): : 41 - 46
[36] Omalizumab treatment in adolescents with chronic spontaneous urticaria: Efficacy and safety
Kahveci, M.
Soyer, O.
Buyuktiryaki, B.
Sekerel, B. E.
Sahiner, U. M.
ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2020, 48 (04) : 368 - 373
[37] Omalizumab treatment in children with chronic spontaneous urticaria: Efficacy and safety
Kahveci, M.
Sahiner, U. M.
Buyuktiryaki, B.
Sekerel, B. E.
Soyer, O.
ALLERGY, 2019, 74 : 867 - 868
[38] Lower efficacy of omalizumab in older adults with chronic spontaneous urticaria
Kitao, Rikuma
Oda, Yoshiko
Washio, Ken
Tai, Yukimasa
Ono, Ryusuke
Nishigori, Chikako
Fukunaga, Atsushi
JOURNAL OF DERMATOLOGY, 2022, 49 (07): : 729 - 731
[39] Comparative efficacy of ligelizumab versus omalizumab in chronic spontaneous urticaria
Moussa, Sarah
Netchiporouk, Elena
LANCET, 2024, 403 (10422): : 118 - 119
[40] Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria
Kaplan, A. P.
Gimenez-Arnau, A. M.
Saini, S. S.
ALLERGY, 2017, 72 (04) : 519 - 533

← 1 2 3 4 5 →